Astrana Health Inc.
Rating
Updated: Aug 25, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical...
Latest News
1 month ago · seekingalpha.com
Astrana Health: 81% Full-Risk And ProfitableAstrana Health is rated a buy, trading at a 46% discount to peers despite sector-wide reserve releases clarifying earnings quality concerns. ASTH's Care Enablement platform drove G&A costs from 7.75% to 5.57% of revenue, quadrupling third-party revenue year-over-year and supporting durable profit at scale. Organic growth is driven by a mix-shift into full-risk capitation, with management projecting ongoing revenue-per-member expansion and a robust conversion pipeline.
2 months ago · seekingalpha.com
Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call TranscriptAstrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript
2 months ago · zacks.com
Astrana Health, Inc. (ASTH) Q2 Earnings Top EstimatesAstrana Health, Inc. (ASTH) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.19 per share a year ago.
2 months ago · marketbeat.com
Astrana Health Q2 Earnings Call HighlightsAstrana Health NASDAQ: ASTH reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrangements, medical-cost management, Prospect Health acquisition synergies and operating leverage.
2 months ago · prnewswire.com
Astrana Health, Inc. Reports Second Quarter 2026 ResultsCompany to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m.
2 months ago · gurufocus.com
A Look at Astrana Health Inc (ASTH) After 3.0% Decline -- GF Value $83.77 vs Price $35.52On July 31, 2026, Astrana Health Inc (ASTH) shares fell 3.0% to a current price of $35.52. The stock has seen significant volatility, with a 52-week range of $1
2 months ago · prnewswire.com
Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference CallALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2026, after the close of the stock market on Thursday, August 6, 2026.
2 months ago · prnewswire.com
Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance YearAll Eight ACOs Achieve Net Shared Savings ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that its Accountable Care Organizations (ACOs) generated $120.4 million in gross shared savings during the 2024 performance year.
3 months ago · zacks.com
Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains?Astrana Health, Inc. (ASTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
4 months ago · prnewswire.com
Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue GrowthALHAMBRA, Calif., June 4, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it has been named to the Fortune 1000® for 2026, marking its debut on the annual ranking of the largest U.S. companies by revenue.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ASTH